ADSL and infection: In order to evaluate the anti-infection therapeutic efficacy of the AMPs obtained from the MultiDS system, a mouse skin wound infection model infected with E. coli (CMCC44103), E. coli (SYPB-3820) (drug-resistance bacteria), and S. aureus (CMCC26003) was established.